Search for: "SANOFI INC." Results 41 - 60 of 436
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jul 2009, 9:28 pm
District Court for the Central District of California denied Sandoz Inc.'s motion seeking attorneys' fees and costs in its patent infringement suit with Sanofi-Aventis. [read post]
15 Mar 2016, 5:09 pm by Kevin LaCroix
Sanofi,1 the Second Circuit interpreted and applied for the first time the Supreme Court’s decision in Omnicare Inc. v. [read post]
25 Mar 2011, 8:26 am
This week Jones Ward PLC filed a lawsuit against sanofi-aventis U.S., Inc. on behalf of the Estate of Samuel Hunter. [read post]
25 Mar 2011, 8:26 am
This week Jones Ward PLC filed a lawsuit against sanofi-aventis U.S., Inc. on behalf of the Estate of Samuel Hunter. [read post]
7 Oct 2009, 9:59 pm
Sanofi originally filed suit against Sun, Sandoz, Actavis Inc., and Par Pharmaceutical Inc., among other generic manufacturers, in June 2007, accusing them of infringing Sanofi's patent covering Eloxatin ®, U.S. [read post]
23 Mar 2006, 10:15 pm
Bristol-Myers Squibb Company and sanofi-aventis announced earlier this week that they have reached a tentative settlement agreement with Apotex Inc. and Apotex Corp. regarding the pending Plavix ® patent infringement lawsuit. [read post]
18 Jul 2022, 2:00 am by Katharine Van Tassel
Gregory Sidak (Criterion Economics, Inc.), Sanofi-Aventis U.S., LLC v. [read post]
27 Jul 2010, 4:55 am by FDABlog HPM
(“Sanofi”) sued FDA over the Agency’s July 23, 2010 approval of Sandoz Inc. [read post]
2 Nov 2014, 8:58 pm by Patent Docs
• Defendants: Sanofi; Aventisub LLC; Regeneron Pharmaceuticals Inc. [read post]
31 May 2023, 9:43 am by Rose Hughes
Cir. 2021), the Supreme Court found Amgen's function and epitope defined PCSK9 antibody patents to lack enablement (Amgen Inc v Sanofi, No. 21-757). [read post]
17 Feb 2007, 7:58 am
The Orange County Business Journal gives some insights into the Lovenox case: The Amphastar Pharmaceuticals Inc. team's defense took a turn in 2004 when the lawyers said they found that Sanofi may have failed to disclose information about dosage sizes in the data submitted to patent examiners. [read post]
11 Feb 2007, 6:51 am
Atrix Laboratories, Inc. and Sanofi-Synthelabo Inc. [read post]